Next Article in Journal
The Viability of Photocatalysis for Air Purification
Previous Article in Journal
Ginsenoside Rc Promotes Anti-Adipogenic Activity on 3T3-L1 Adipocytes by Down-Regulating C/EBPα and PPARγ
Article Menu

Export Article

Open AccessArticle
Molecules 2015, 20(1), 1304-1318; doi:10.3390/molecules20011304

Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease

1,†
,
2,†
,
1,* , 2
,
2
,
1
and
1,*
1
Institute of Natural Medicine, Hefei University of Technology, Hefei 230009, Anhui, China
2
Anhui Province Key Laboratory of R&D of Chinese Medicine, Anhui University of Chinese Medicine, Hefei 230038, Anhui, China
These authors contributed equally to this work.
*
Authors to whom correspondence should be addressed.
Academic Editor: Derek J. McPhee
Received: 10 November 2014 / Accepted: 7 January 2015 / Published: 14 January 2015
(This article belongs to the Section Organic Synthesis)
View Full-Text   |   Download PDF [2672 KB, uploaded 21 January 2015]   |  

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative brain disorder characterized by memory loss, language impairment, personality changes and intellectual decline. Taking into account the key pathological features of AD, such as low levels of acetylcholine, beta-amyloid (Aβ) aggregation, oxidative stress and dyshomeostasis of biometals, a new series of paeonol derivatives 5a5d merging three different functions, i.e., antioxidant, anti-acetylcholinesterase (AChE) activity, metal chelating agents for AD treatment have been synthesized and characterized. Biological assays revealed that compared with paeonol (309.7 μM), 5a5d had a lower DPPH IC50 value (142.8–191.6 μM). 5a5d could significantly inhibit hydrogen peroxide-induced neuronal PC12 cell death assessed by MTT assay in the concentration range of 5–40 μM. AChE activity was effectively inhibited by 5a5d, with IC50 values in the range of 0.61–7.04 μM. 5a5d also exhibited good metal-chelating ability. All the above results suggested that paeonol derivatives may be promising multifunctional agents for AD treatment. View Full-Text
Keywords: Alzheimer’s disease; multifunctional agents; paeonol; acetylcholinesterase inhibitors; metal-chelating; biometal chelators Alzheimer’s disease; multifunctional agents; paeonol; acetylcholinesterase inhibitors; metal-chelating; biometal chelators
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Zhou, A.; Wu, H.; Pan, J.; Wang, X.; Li, J.; Wu, Z.; Hui, A. Synthesis and Evaluation of Paeonol Derivatives as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease. Molecules 2015, 20, 1304-1318.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top